NEU

5.50%

$16.15 neuren pharmaceuticals limited

Lily.Very good post .I think the bell potter analyst is gun...

First 8 Last

Share
Profile

Follow
Little T

2,326 Posts.

1991

03/07/17

13:00

Post #: 25629618
Share

Originally posted by lilypily ↑

I was just reviewing the Bell potter valuation from July 2015 (25c) vs July 2017 (13c)

Keep in mind since July 2015 we have had
1) Success in phase 2b Retts
2) Success in phase 2 FX
3) Fail in TBI with a re-trial on the cards

and ill exclude all the other things like extended patents, the new FX like Syndrome etc

Retts:
in 2015 they attribute a probability adjusted NPV for retts of $149 mill and now in 2017 we have have a phase 2b success and almost ready to get P3 ticked off and a NPV increase of just 11 mill ($160 mil!). Global sales and market share etc haven't been altered (and are very conservative)

FX:
in 2015 the probability adjusted NPV is $132 mill and now in 2017 they list it as $105mill . So success in phase 2 has dropped the NPV.....?????

Also interesting in the FX valuation they use chance of success at 25% vs 30% they used for retts at the same stage (not really here or there though). Peak market share is half of Retts, again not sure the rationale behind that considering drug costs are similar and demand is going to be similar (50% used in retts) and global market sales still very very conservative.

So we are far more progressed, we are derisked and nearly ready to roll out a phase 3 + phase 2b program yet we are at half the valuation....

I don't really take any note of these reports but it does give you an idea of the scale we are dealing with once we derisk further. That has to be after the FDA meeting . I also believe the consolidation is definitely a strategic move to get buying pressure in the lead up to that event. So if anyone wants a decent position they better hurry because if we only have 100 mill shares on issue the share price/ market cap will not be sitting at 120 mill for long.

Expand

Lily.Very good post .I think the bell potter analyst is gun shy.They have had a couple of bad calls and they have done a turtle and retracted into their shell!!!!As usual a deal will be done and they will be speechless !!!

NEU Price at posting: 6.9¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

NEU

Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress

TNC

True North increases silver metal at QLD's Vero deposit by 20%

From the Floor with Federal Opposition Leader Peter Dutton at Diggers & Dealers 2024

Bitcoin: Current State of Play & Where to Next | Swyftx

TKM

Trek Metals jumps 5% as gold & REE drill run kicks off at Christmas Creek in the Kimberley

Revolutionary inverter technology leads the clean energy charge

Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling

Emerald & Azure score Digger & Dealer awards

Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market

HZR

Hazer Group reports ten days of continuous operation at graphite-manufacturing test facility

There are more pages in this discussion • 36 more messages in this thread...

First 8 Last

Add NEU (ASX) to my watchlist

(20min delay)
Last $16.15		Change -0.940(5.50%)		Mkt cap ! $2.064B

Open	High	Low	Value	Volume
$15.04	$16.33	$14.65	$25.91M	1.638M

Buyers (Bids)

No.	Vol.	Price($)
1	125	$16.15

Sellers (Offers)

Price($)	Vol.	No.
$16.20	1500	1

View Market Depth

No.	Vol.	Price($)
1	125	16.150
1	650	16.110
1	500	16.100
2	510	16.050
1	662	16.040

Price($)	Vol.	No.
16.200	1500	1
16.290	10000	1
16.500	1250	2
16.600	100	1
16.750	1000	1

Last trade - 16.10pm 09/08/2024 (20 minute delay)

NEU (ASX) Chart

Lily.Very good post .I think the bell potter analyst is gun...

Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress

True North increases silver metal at QLD's Vero deposit by 20%

From the Floor with Federal Opposition Leader Peter Dutton at Diggers & Dealers 2024

Bitcoin: Current State of Play & Where to Next | Swyftx

Trek Metals jumps 5% as gold & REE drill run kicks off at Christmas Creek in the Kimberley

Revolutionary inverter technology leads the clean energy charge

Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling

Emerald & Azure score Digger & Dealer awards

Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market

Hazer Group reports ten days of continuous operation at graphite-manufacturing test facility

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Lily.Very good post .I think the bell potter analyst is gun...

Top Stories

Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress

True North increases silver metal at QLD's Vero deposit by 20%

From the Floor with Federal Opposition Leader Peter Dutton at Diggers & Dealers 2024

Bitcoin: Current State of Play & Where to Next | Swyftx

Trek Metals jumps 5% as gold & REE drill run kicks off at Christmas Creek in the Kimberley

Revolutionary inverter technology leads the clean energy charge

Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling

Emerald & Azure score Digger & Dealer awards

Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market

Hazer Group reports ten days of continuous operation at graphite-manufacturing test facility

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News